BANK OF AMERICA CORP /DE/ - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 25 filers reported holding MOLECULIN BIOTECH INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q4 2020$32,000
-3.0%
39,900
-1.7%
0.00%
Q3 2020$33,000
-15.4%
40,577
+1.7%
0.00%
Q2 2020$39,000
+95.0%
39,900
+59.6%
0.00%
Q1 2019$20,000
-23.1%
25,0000.0%0.00%
Q4 2018$26,000
-35.0%
25,0000.0%0.00%
Q3 2018$40,000
-11.1%
25,0000.0%0.00%
Q2 2018$45,0000.0%25,0000.0%0.00%
Q1 2018$45,000
-4.3%
25,0000.0%0.00%
Q4 2017$47,000
-21.7%
25,0000.0%0.00%
Q3 2017$60,000
+27.7%
25,0000.0%0.00%
Q2 2017$47,000
+62.1%
25,0000.0%0.00%
Q1 2017$29,000
-49.1%
25,0000.0%0.00%
Q4 2016$57,00025,0000.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q3 2020
NameSharesValueWeighting ↓
Whitegate Investment Counselors, Inc. 101,781$81,0000.01%
Levy Wealth Management Group, LLC 14,036$11,0000.01%
WOODMONT INVESTMENT COUNSEL LLC 12,000$10,0000.00%
Renaissance Technologies 948,503$756,0000.00%
Qube Research & Technologies Ltd 132,238$105,0000.00%
Core Wealth Advisors, Inc. 1,711$1,0000.00%
UBS Group AG 36,726$29,0000.00%
IFP Advisors, Inc 0$00.00%
Squarepoint Ops LLC 12,342$10,0000.00%
TRUE Private Wealth Advisors 2,500$1,0000.00%
View complete list of MOLECULIN BIOTECH INC shareholders